Startup Dossier
FineHeart
FineHeart is a clinical-stage medical technology company developing next-generation Active Implantable Medical Devices (AIMDs) for advanced heart failure. Its flagship product, FlowMaker®, is the world's first fully implantable cardiac output accelerator, designed to work in synergy with natural heart contractions while minimizing energy consumption and infection risk.
About
FineHeart is a clinical-stage medical technology company developing next-generation Active Implantable Medical Devices (AIMDs) for advanced heart failure. Its flagship product, FlowMaker®, is the world's first fully implantable cardiac output accelerator, designed to work in synergy with natural heart contractions while minimizing energy consumption and infection risk.
Structural DNA
Legal Name
FineHeart
SIREN
519375356
Founders & Team
Funding Lineage
Series C
Groupe Pasteur Mutualité (Lead)
€35.0M
Jan 2026
Series C
European Innovation Council (Lead)
€15.0M
Oct 2022